Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: a prospective study in 35 patients
- PMID: 17114803
- DOI: 10.1093/rheumatology/kel376
Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: a prospective study in 35 patients
Abstract
Objective: To study fluorodeoxyglucose (FDG) deposition in different vascular beds and in the large joints of patients with isolated polymyalgia rheumatica (PMR), and to investigate whether there is a relation between FDG-positron emission tomography (PET) results and risk of relapse.
Methods: All consecutive patients with isolated PMR underwent a FDG-PET scan before treatment with steroids was started and--if logistics allowed--at 3 and 6 months. PET scans were scored at seven different vascular areas and a total vascular score (TVS) was calculated, ranging from 0 to 21. FDG uptake in the shoulders, the hips and the processi spinosi of the vertebrae was scored as 0 (no uptake), 1 (moderate uptake) or 2 (intense uptake).
Results: Thirty-five patients entered the study. At diagnosis, vascular FDG uptake was noted in 11 patients (31%), predominantly at the subclavian arteries. Mean TVS was low. FDG uptake in the shoulders was noted in 94% of patients, in the hips in 89% and in the processi spinosi of the vertebrae in 51%. The intensity of FDG uptake in the large vessels or in the shoulders, hips or processi spinosi did not correlate with the risk of relapse.
Conclusions: Only one in three patients has an (moderately) increased vascular FDG uptake, especially in the subclavian arteries. The vast majority has inflammation of shoulders and hips, and half of them have increased FDG-uptake at the processi spinosi. Results of FDG-PET scans in patients with PMR did not correlate with their risk of relapse.
Comment in
-
Is FDG-PET useful in the evaluation of steroid-resistant PMR patients?Rheumatology (Oxford). 2008 Jun;47(6):926-7. doi: 10.1093/rheumatology/ken098. Epub 2008 Apr 4. Rheumatology (Oxford). 2008. PMID: 18390582 No abstract available.
Similar articles
-
Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients.Arthritis Rheum. 2006 Feb 15;55(1):131-7. doi: 10.1002/art.21699. Arthritis Rheum. 2006. PMID: 16463425 Clinical Trial.
-
Whole-body fluorodeoxyglucose positron emission tomography/computed tomography in patients with active polymyalgia rheumatica: evidence for distinctive bursitis and large-vessel vasculitis.Mod Rheumatol. 2012 Sep;22(5):705-11. doi: 10.1007/s10165-011-0581-x. Epub 2011 Dec 29. Mod Rheumatol. 2012. PMID: 22205118
-
PET-CT findings in patients with polymyalgia rheumatica without symptoms of cranial ischaemia.Dan Med J. 2017 Oct;64(10):A5410. Dan Med J. 2017. PMID: 28975885
-
18F-FDG PET/CT in polymyalgia rheumatica-a pictorial review.Br J Radiol. 2017 Aug;90(1076):20170198. doi: 10.1259/bjr.20170198. Epub 2017 Jun 16. Br J Radiol. 2017. PMID: 28508663 Free PMC article. Review.
-
Diagnostic value of [18F]FDG-PET/CT in polymyalgia rheumatica: a systematic review and meta-analysis.Eur J Nucl Med Mol Imaging. 2021 Jun;48(6):1876-1889. doi: 10.1007/s00259-020-05162-6. Epub 2020 Dec 28. Eur J Nucl Med Mol Imaging. 2021. PMID: 33372248 Free PMC article. Review.
Cited by
-
Giant-cell arteritis without cranial manifestations: Working diagnosis of a distinct disease pattern.Medicine (Baltimore). 2016 Jun;95(26):e3818. doi: 10.1097/MD.0000000000003818. Medicine (Baltimore). 2016. PMID: 27367984 Free PMC article.
-
Evolving role of FDG PET imaging in assessing joint disorders: a systematic review.Eur J Nucl Med Mol Imaging. 2011 Oct;38(10):1939-55. doi: 10.1007/s00259-011-1863-4. Epub 2011 Jul 14. Eur J Nucl Med Mol Imaging. 2011. PMID: 21755370 Review.
-
The role of imaging in polymyalgia rheumatica/giant cell arteritis.Skeletal Radiol. 2008 Sep;37(9):779-83. doi: 10.1007/s00256-008-0541-5. Skeletal Radiol. 2008. PMID: 18594807 Review. No abstract available.
-
[Myalgia in polymyalgia rheumatica, temporal arteritis and other vasculitides].Z Rheumatol. 2009 Aug;68(6):446-50. doi: 10.1007/s00393-009-0453-3. Z Rheumatol. 2009. PMID: 19585133 Review. German.
-
Chronic rheumatologic disorders and cardiovascular disease risk in women.Am Heart J Plus. 2023 Feb 9;27:100267. doi: 10.1016/j.ahjo.2023.100267. eCollection 2023 Mar. Am Heart J Plus. 2023. PMID: 38511090 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical